ENTRY       D05597                      Drug
NAME        Prasugrel hydrochloride (JAN/USAN);
            Effient (TN)
PRODUCT     EFFIENT (Cosette Pharmaceuticals)
            EFFIENT (Daiichi Sankyo)
  GENERIC   PRASUGREL (A-S Medication Solutions)
            PRASUGREL (Accord Healthcare)
            PRASUGREL (American Health Packaging)
            PRASUGREL (Amneal Pharmaceuticals LLC)
            PRASUGREL (Apotex Corp.)
            PRASUGREL (Aurobindo Pharma Limited)
            PRASUGREL (Golden State Medical Supply)
            PRASUGREL (Mylan Pharmaceuticals)
            PRASUGREL (Panacea Biotec Limited)
            PRASUGREL (Unichem Pharmaceuticals (USA))
FORMULA     C20H20FNO3S. HCl
EXACT_MASS  409.0915
MOL_WEIGHT  409.902
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01712  Antiplatelet agent
               DG01808  Thienopyridine
             DG01809  P2Y12 receptor antagonist
              DG01808  Thienopyridine
REMARK      Therapeutic category: 3399
            ATC code: B01AC22
            Product: D05597<JP/US>
EFFICACY    Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist
  DISEASE   Unstable angina [DS:H01632]
            Myocardial infarction [DS:H01730]
COMMENT     Thienopyridine derivative
TARGET      P2RY12 [HSA:64805] [KO:K04298]
  PATHWAY   hsa04611(64805)  Platelet activation
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC22 Prasugrel
                  D05597  Prasugrel hydrochloride (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Products and Modifiers
              Platelet Modifying Agents
               Adenosine Diphosphate P2Y12 Inhibitors
                Prasugrel
                 D05597  Prasugrel hydrochloride (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              33  Blood and body fluid agents
               339  Miscellaneous
                3399  Others
                 D05597  Prasugrel hydrochloride (JAN/USAN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG01808  Thienopyridine
                 D05597  Prasugrel hydrochloride
              DG01809  P2Y12 receptor antagonist
               DG01808  Thienopyridine
                D05597  Prasugrel hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Purine / pyrimidine
                P2RY12
                 D05597  Prasugrel hydrochloride (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05597
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05597
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D05597
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05597
DBLINKS     CAS: 389574-19-0
            PubChem: 47207260
            ChEBI: 87697
            LigandBox: D05597
ATOM        27
            1   N1y N    17.0100  -15.7500
            2   C1x C    17.0100  -14.3500
            3   C1x C    18.2000  -13.6500
            4   C8y C    19.4600  -14.3500
            5   C8y C    19.4600  -15.7500
            6   C1x C    18.2000  -16.4500
            7   S2x S    20.7900  -13.9300
            8   C8y C    21.5600  -15.0500
            9   C8x C    20.7900  -16.1700
            10  O7a O    22.9600  -15.0500
            11  C7a C    23.6600  -13.8600
            12  C1a C    25.0600  -13.8600
            13  O6a O    22.9600  -12.6700
            14  C1c C    15.8200  -16.4500
            15  C8y C    14.6300  -15.7500
            16  C5a C    15.8200  -17.8500
            17  O5a O    17.0100  -18.5500
            18  C1y C    14.6300  -18.5500
            19  C8y C    14.6300  -14.3500
            20  C8x C    13.3700  -13.6500
            21  C8x C    12.1800  -14.3500
            22  C8x C    12.1800  -15.7500
            23  C8x C    13.3700  -16.4500
            24  C1x C    13.2300  -18.5500
            25  C1x C    13.9300  -19.7400
            26  X   F    15.8200  -13.6500
            27  X   Cl   24.7800  -18.0600
BOND        29
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 2
            5     5   6 1
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 2
            10    5   9 1
            11    8  10 1
            12   10  11 1
            13   11  12 1
            14   11  13 2
            15    1  14 1
            16   14  15 1
            17   14  16 1
            18   16  17 2
            19   16  18 1
            20   15  19 2
            21   19  20 1
            22   20  21 2
            23   21  22 1
            24   22  23 2
            25   15  23 1
            26   18  24 1
            27   24  25 1
            28   25  18 1
            29   19  26 1
///
